Latest News about BNTX
Recent news which mentions BNTX
7 Vaccine Stocks to Sell ASAP Now That the ‘Pandemic’s Over’
September 27, 2022
From InvestorPlace
Pfizer and BioNTech seek authorization of omicron-targeted booster for children aged 5 to 11
September 26, 2022
From MarketWatch
iPhone 14 Popular In China?, Netflix May Lose Comics, Elon Musk's Starlink Slows, Byron Allen Faces $10B Lawsuit And More Top Financial Media Stories Monday, Sept. 26
September 26, 2022
From Benzinga
Pfizer/BioNTech Seek FDA Emergency Nod For Updated COVID-19 Shot For Kids Under 11 Years
September 26, 2022
From Benzinga
Pfizer CEO Contracts COVID-19 Infection For Second Time
September 26, 2022
From Benzinga
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Kids, But Scrambles Supply Challenges
September 26, 2022
From Benzinga
Switzerland To Dispose 10M Expired COVID-19 Vaccine Doses From Moderna
September 26, 2022
From Benzinga
Health official says updated COVID-19 boosters likely to be available in weeks for elementary school-age children
September 22, 2022
From MarketWatch
Why Is Novavax (NVAX) Stock Falling Today?
September 22, 2022
From InvestorPlace
From MarketWatch
Nikola, Super Micro Computer And Other Big Losers From Monday
September 20, 2022
From Benzinga
Vaccine Stocks: Down but Not Out?
September 19, 2022
From Motley Fool
Why Moderna Stock Dropped Today
September 19, 2022
From Motley Fool
Why Are Vaccine Stocks MRNA, PFE, NVAX, BNTX Down Today?
September 19, 2022
From InvestorPlace
Health experts dismayed by President Biden’s view that the pandemic is over: ‘Hell no — not even close’
September 19, 2022
From MarketWatch
Why BioNTech, Moderna And Novavax Shares Are Diving
September 19, 2022
From Benzinga
Pfizer Starts Pivotal Phase 3 Study of mRNA-Based Influenza Vaccine
September 14, 2022
From Benzinga
U.S. known COVID cases hold at lowest level since May, but infections are rising again in New York
September 13, 2022
From MarketWatch
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
September 12, 2022
From Benzinga
Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary
September 09, 2022
From Benzinga
Why Novavax Stock Sank to a New 52-Week Low Today
September 06, 2022
From Motley Fool
Sanofi-GSK COVID-19 Vaccine May See European Approval Soon: Report
September 06, 2022
From Benzinga
White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox
September 02, 2022
From Benzinga
COVID boosters that target dominant omicron strains set to start in coming days after CDC gives its OK
September 02, 2022
From MarketWatch
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
September 01, 2022
From Benzinga
Europe Backs Approval Of Omicron-Adapted COVID-19 Vaccines
September 01, 2022
From Benzinga
Has it been two months since your last COVID-19 shot? You may soon qualify for a newly designed booster
September 01, 2022
From MarketWatch
2 Big Red Flags and 1 Small Green Flag For Pfizer Stock
September 01, 2022
From Motley Fool